News & Press: News Relating to Practice

Email to a Friend

Telemedicine prescribing flexibilities extended through 2025 Thursday, December 5, 2024   (0 Comments) Posted by: Leigh Stehlik Share | The U.S. Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) have issued a rule that temporarily extends pandemic-era telemedicine prescribing flexibilities for controlled substances through December 31, 2025. The rule marks the third temporary extension of these flexibilities, which authorize a practitioner to prescribe controlled substances via telemedicine, even when the practitioner has not conducted an in-person patient evaluation. « Back to Index